Introduction
End-stage renal disease (ESRD) is characterized by the accumulation of endogenous and/or exogenous toxins that complicate patient's clinical status and need to be removed. Peritoneal dialysis (PD) is a valuable therapy to achieve this goal in paedriatric and young adult ESRD patients. Overall, PD is safe and programmed to be continued over years even if adverse effects may concur to progressive deterioration of peritoneal membrane (PM) permeability and function, and limit PD duration [1] . One is continuous PM exposure to PD solutions with high concentration of osmotic agents that determine chronic activation of macrophages and production of reactive oxygen species (ROS); the other is the occurrence of acute inflammatory episodes that adversely affect patient's clinical status [2] [3] [4] [5] [6] [7] [8] . Technology developments in PD devices and solutions are deeply necessary to improve safety and biocompatibility of the technique.
One basic problem in considering PD solutions is how to determine the balance between removal efficiency of toxic molecules and loss of other substances with physiologic effects such as enzymes, carrier proteins, vitamins and others. An arbitrary limit between positive effects and unwanted consequences is the molecular weight of substances removed during PD since it has been hypothesized that substances in the range of middle molecules and/ or low-molecular-weight proteins (LMWP) play important clinical effects in uraemia [9, 10] . Based on these considerations, β2-microglobulin and cystatin C have been taken as biomarkers of PD efficiency, while other proteins with high molecular weight are candidates to be considered as biomarkers of unwanted effects [11] [12] [13] . With the development of proteomic technologies that deeply amplify the power of protein profile analysis in fluids, the literature on the topics is growing but is mainly dedicated to adults which may present additional factors influencing PM stability such as diabetes and atherosclerosis.
In this study, we compared the proteomic profile of peritoneal dialysis effluents (PDE) obtained with icodextrin-based (Ico) or glucose-based (Glu) PD solutions in paediatric patients using classic proteomic techniques such as two-dimensional electrophoresis and mass spectrometry. Specific procedures for defining the oxido-redox status of proteins have also been used to clarify their role as firstline defence against toxic radicals generated by chronic activation of macrophages during PD treatment.
Materials and methods

Patients
We studied 16 patients, with an age of 12.9 ± 4.7 years, body weight of 36.5 ± 16.4 kg and body height of 135.1 ± 26.2 cm. Body surface area (BSA), calculated by means of the Haycock formula [14] , was 1.17 ± 0.37 m [15] . Patients' primary renal diseases were represented by renal dysplasia in six cases, focal segmental glomerulosclerosis in four cases, nephronophthisis in two cases, and cystinosis, reflux nephropathy, hyperuricaemic nephropathy and cortical necrosis in one case each. At the moment of the study, patients had been on automated PD (APD) with glucose-based PD solutions for a mean of 7.1 months (range 3-30 months), and none of them had ever been treated with icodextrin-based PD solutions. Patients had not suffered from any peritonitis and/or exitsite infection episode for at least 1 month before the study (Table 1) .
Written, informed consent was obtained from patients and their parents.
Study protocol and sample collection
Study protocol consisted of two 14-h daytime dwells, performed on two subsequent days with a 7.5% w/v Ico solution (Extraneal, Baxter, Deerfield, IL, USA) and a 3.86% w/v Glu solution (Dianeal, Baxter). A 3.86% Glu solution was employed in order to perform the two experimental dwells under similar test conditions in terms of ultrafiltration rate. The dwell volume employed during the 14-h daytime dwell was 700 ± 229 mL, which corresponded to 594 ± 78 mL/m [15] BSA.
A dialysate sample was taken at the end of the dwell, when patient's abdomen was accurately drained and dialysate volume was measured. Each dialysate sample was divided into two aliquots: one was assayed for β2-microglobulin and for cystatin C; the second was assayed by means of proteomic analysis. This sample was centrifuged at 10 000 g for 15 min to remove cells and debris. Supernatants were stored at −80°C until use. Sample protein concentration was determined using bicinchoninic acid assay. A dialysate sample was also taken at 0, 4 and 8 h of the dwell to study peritoneal transport kinetics of β2-microglobulin and cystatin C.
A blood sample was taken before and after PD to evaluate the oxidoredox status of proteins.
Peritoneal membrane transport function was evaluated by means of a 4-h peritoneal equilibration test [16] , by using a 1100-mL/m 2 BSA dwell volume; classification of peritoneal transport rate was performed by comparing the results of the test with the available paediatric standards [17] .
Chemical reagents
All chemical reagents were analytical grade (Fluka, Buchs, CH). Solutions were freshly prepared using bi-distilled Milli-Q water.
Two-dimensional electrophoresis Two-dimensional PAGE was performed using homemade strips in a nonlinear pH 3-10 interval (18 cm long, 3 mm wide and 0.50 mm thick) [18] . The re-swelling of strips was carried out overnight at room temperature in a focusing solution, i.e. 7 M urea, 2 M thiourea, 2% w/v 3-[3-(cholamidopropyl)-dimethylammonio]-1-propanesulphonate (CHAPS), 15 mM dithioerythritol (DTE) and a 0.6% v/v carrier ampholyte cocktail, containing 40% of the pH 3.5-10 and 60% of the pH 4-8 intervals.
Samples (1 mL) were cleaned and precipitated using a solution consisting of tri-n-butyl-phosphate:acetone:methanol (1:12:1), cooled in ice to remove all contaminants, i.e. salts, lipids and the two osmotic agents, that affect on IEF runs. Cleaned mixture was added to each sample to reach a final acetone concentration of 80% v/v and incubated at 4°C for 90 min. The precipitate was pelleted by centrifugation at 2800 g for 15 min at 4°C. After washing with the same de-lipidizing solution, it was centrifuged again and then air-dried. Finally, samples were dissolved in the focusing solution, i.e. 7 M urea, 2 M thiourea, 4% w/v CHAPS and 65 mM DTE.
The protein was focused at ≤50 μA per strip at 20°C, using progressively increasing voltage for a total of 80 kVh in a PROTEAN IEF cell (Bio-Rad, Hercules, CA, USA).
Strips were equilibrated in 6 M urea, 50 mM Tris-HCl pH 8.8, 2% w/v SDS, 20% v/v glycerol, 0.0001% w/v bromophenol blue and 2% w/v DTT for 15 min, followed by the same buffer without DTE, but with the addition of 3% w/v iodoacetamide. The second dimension was run on 8-16% T gels in a Protean II XI system (Bio-Rad).
Proteins were stained by blue silver colloidal Coomassie [19] for mass spectrometry identification and silver staining for analytical gels. Images were digitized by means of GS-800 scanner (Bio-Rad).
Labelling of proteins with fluorescence probe and SDS-PAGE
Equal amounts of each sample (30 μg) were labelled with C3NIASO3 fluorescence dye (Cyanagen, Bologna, Italy) according to Bruschi et al. [20] . Briefly, 400 pmol of dye for microgram of proteins was solubilized in 8 M urea, 4% w/v CHAPS, 10 mM Tris-HCl, pH 8.8, 1 mM EDTA and 5 mM tributylphosphine for 1 h. The reaction was quenched with 100 mM DTE for 1 h. All steps were performed at room temperature in a dark box and a gentle shaker. Finally, samples were loaded on 8-16% T SDS-PAGE gels. Images were digitized by means of FX Pro laser scanner (Bio-Rad) at excitation of 532 nm and emission of 555 nm.
Tryptic digestion and protein identification by LC-ESI MS-MS/MS
Protein spots were excised from a gel, rinsed in 50% v/v acetonitrile (ACN) in 5 mM ammonium bicarbonate pH 8.9 until full decolouration, rinsed twice in 100% v/v ACN, and briefly rinsed in 1 mM CaCl 2 and 100 mM ammonium bicarbonate pH 8.9. Enzymatic digestions were performed using trypsin in 100 mM ammonium bicarbonate buffer pH 7.8 overnight at 37°C. After incubation, the reaction was quenched by the addition of formic acid to pH 2.
All mass spectrometric measurements were performed using a LTQ linear ion trap mass spectrometer (Thermo Electron, San Jose, CA, USA) coupled to a HPLC Surveyor (Thermo Electron) and equipped with a Jupiter C18 column 250 mm × 1 mm (Phenomenex). Peptides were eluted from the column using an acetonitrile gradient, 5% v/v B for 6 min followed by 5-90% v/v B within 109 min (eluent A: 0.1% v/v formic acid in water; eluent B: 0.1% v/v formic acid in acetonitrile) at a flow rate of 50 µL/min. The column effluent was directed into the electrospray source. The spray voltage was 5.0 kV. The ion trap capillary was kept at 200°C, and the voltage was kept at 2.85 V. The spectra were obtained in automated MS/MS mode: each full MS scan (400-1800 m/z) was followed by five MS/MS of the most abundant ions. The ions analysed in this way were automatically excluded for 30 s.
Protein identification was performed using SEQUEST software, from Thermo Electron Corporation, operating on a 10-processor computer cluster (AETHIA, Turin, Italy), and searched against a Canis protein database downloaded by NCBI using the taxonomy browser tool. Peptide MS/MS assignments were filtered following very high stringent criteria: Xcorr ≥1.9 for the singly charged ions, Xcorr ≥2.2 for doubly charged ions, Xcorr ≥3.7 for triply charged ions, peptide probability ≤0.01, delta Cn ≥0.1 and Rsp ≤4.26 [21] . To identify the largest panel of peptides, the option no enzyme was used for the in silica digestion of human databases.
Measurement of β2-microglobulin and cystatin C β2-Microglobulin was estimated by solid-phase, two-site chemiluminescent immunometric assay with Immulite 2000 analyser (Siemens Medical Solutions Diagnostics, Los Angeles, CA, USA).
Cystatin C concentration was determined with a diagnostic kit 'N Latex Cystatin C' by means of particle-enhanced immunonephelometry using the BN systems (Siemens Medical Solutions Diagnostics).
Image and statistical analysis
All digitalized images were analysed with PDQuest Advance or QuantyOne software (Bio-Rad).
Results are expressed as mean±SD and analysed by non-parametric Wilcoxon test for paired samples using GraphPad Prism 4 software. Differences were considered statistically significant at two-tailed P-values <0.05.
Results
Peritoneal membrane efficiency in LMWP removal
PM efficiency in LMWP removal, which occurs by diffusion and convection, was evaluated using β2-microglobulin and cystatin C as markers. As shown in Table 2 , dialysate concentrations of β2-microglobulin and cystatin C were, respectively, 10.34 and 2.01 mg/dL in Ico and 7.86 and 1.58 mg/dL in Glu with a similar net ultrafiltration rate for Ico and Glu solutions (i.e. 24.4 ± 15.3% of the infused volume with Ico and 22.7 ± 21.7% with Glu). Moreover, peritoneal transport kinetics of β2-microglobulin and of cystatin C in function of time was linear for both Ico (r= 0.968 and r=0.993, respectively) and Glu solutions (r= 0.998 and r=0.999, respectively) ( Figure 1A ), but removal was higher with Ico than with Glu (P<0.05) ( Figure 1B and C). Overall, this first set of data indicates a higher efficiency of Ico solution in removing these two LMWPs.
Protein removal by different PD regimens
Overall. The amount of total proteins in PDE was mainly influenced by the efficiency of PM and remained constant in a given patient during the two different PD procedures. In fact, there was a linear correlation between the protein removal during Ico and Glu dialysis in the same patient who underwent the different PD regimens in two subsequent days (Figure 2 ), suggesting that protein removal is a function of PM characteristics. It is also clear from the graphic presented in Figure 2 that, at low removal levels, Ico removed higher amounts of proteins compared with Glu solutions by a factor of 3.
Starting from this basic observation, we attempted to characterize the panel of proteins in PDE by two-dimensional PAGE (Figure 3) and their oxido-redox status by specific labelling assays (see below). Image analysis of two-dimensional PAGE gels indicated the presence of 1064 and 774 spots, respectively, in Ico and Glu effluents, 524 of which were found in both conditions. Among them, 314 spots were significantly higher in Ico compared with Glu effluents, and were, for this reason, characterized by LC-MS or on the basis of their mass and isoelectric point Table 2 . referred to available databases (www.expasy.org) ( Table 3) . These spots corresponded to 30 intact proteins with various molecular weights and to protein fragments, mainly of albumin. High-and medium-molecular-weight proteins (HMMWP). All the proteins, which were identified in PDE, were plasma proteins. Overall, serotransferrin, albumin, α1-antitrypsin and α1-microglobulin, which are biomarkers of high-(serotransferrin 80 kDa and albumin 67 kDa) and medium-molecular-weight (α1-antitrypsin 55 kDa and α1-microglobulin 30 kDa) proteins, represented 60% of the totality, as expected from their high levels in serum. PDE concentration of all these proteins is shown in Table 3 . PDE levels of HMMWP were variable among patients and followed the same correlation observed with all proteins, which is an intrinsic characteristic of any single patient. PDE concentrations of high-and medium-molecular-weight components were higher with Ico than Glu, especially in patients with the lowest removal rate.
Fragmentation products. Finally, fragmentation products of albumin (see Spot 19, 29 and 37-44), C3 complement (Spot 16 and 31) and fibrinogen β chain (Spot 34 and 35) were present in all patients with a higher intensity in Ico effluents.
Oxido-redox status of proteins
The oxido-redox status of albumin was evaluated determining the binding of specific dyes to the unique free SH (Cys 34) of the protein. Oxidation of this group abolished the binding of fluorescent dyes and determined a decreased signal intensity indicating a high level of protein oxidation. Indeed, it is known that serum albumin is partially oxidized in ESRD patients. An important observation here reported about the oxido-redox status of albumin was that PD, particularly when performed with Ico solution, removed oxidized serum albumin (Table 4 ). In fact, as shown in Figure 4A and B, the amount of oxidized albumin in PDE was higher than in serum and in Ico than in Glu PDE (Figure 4) . The same variation in oxidoredox status was confirmed for other serum and PDE proteins visualized by SDS-PAGE (Figure 4 ).
Discussion
PD is the treatment of choice for ESRD in children while awaiting renal transplantation. The great majority of paediatric patients are treated with APD since this modality ensures good clinical results together with a high level of Fig. 2 . Correlation between total protein concentration in icodextrin and glucose effluents (r = 0.974). Protein concentration in icodextrin was higher than in glucose (P=0.008), especially if peritoneal membrane permeability to proteins was low. patient's psychological and social rehabilitation [22] . For these patients, icodextrin solution represents a potential evolution over other PD solutions to enhance fluid and small molecule removal [23] . A second aspect related to improved molecule removal, and that appears to be a drawback, is a potential loss of HMMWP such as enzymes, transport proteins and others that play physiological functions. Once again, only partial data are available on the composition in protein of PDE that limit any clinical consideration. In this respect, this is the first study on PDE Proteins were identified by LC-mass spectrometry (LC/MS) or their mass and isoelectric point (2D-P). Spot intensity levels were reported in arbitrary unit. proteome profile in children and young adults with ESRD that compares the effect of Ico and Glu as osmotic agents in two PD dwells performed in subsequent days. This approach greatly reduced variability due to personal characteristics of peritoneum that was found as the major factor influencing filtration of proteins and put the basis for a solid comparison between different dialysis regimens. The concept of peritoneal protein loss goes behind a pure quantitative consideration since in some cases, such as with albumin, there are important new functional implications of the protein that may have a key role in the PM response to stress and infection. Albumin is now considered the major antioxidant of plasma [24, 25] and likely plays the same function in peritoneum. In vitro studies demonstrated, in fact, a main role of albumin as antioxidant, and its chemical modification represents a reliable marker of oxidative stress.
In respect to the first two points related to removal of toxic low-molecular-weight and potential helpful substances, we obtained the following relevant results: (i) protein loss is a characteristic of any given patient and is a function of its peritoneum permeability with a linear correlation between protein loss in PDE during Ico and Glu; (ii) high-and low-molecular-weight proteins are removed with the same efficiency and with the same correlation linked to personal characteristics that was observed for β2-microglobulin, still maintaining a proportion of 1:10 in favour of low-molecular-weight proteins; and (iii) in those patients that can be defined as 'low losers' for the low concentration of proteins in PDE, Ico achieves a much higher loss by a factor of 2-4 of both high-and lowmolecular-weight components.
Therefore, the efficiency of any given peritoneum to remove high-and low-molecular-weight components is a peculiarity of a single patient. While removal of LMWP can be considered a favourable effect of PD, loss of HMMWP may produce functional changes that adversely affect patients on chronic PD. This issue is of clinical importance in uraemic patients since the loss of HMMWP, as albumin or immunoglobulins, may contribute to the development of clinical complications, like protein malnutrition and infection [9, 10] . On the other hand, the removal of LMWP, like β2-microglobulin or leptin, is to be considered beneficial since their accumulation may contribute to uraemic toxicity [9, 10, 13] .
Overall, our data are in agreement with other studies on the transport of HMMWP and LMWP in adults undergoing PD and also confirmed studies in children [15, [26] [27] [28] [29] [30] .
A point of interest that has not been considered before is the oxido-redox status of albumin in PDE. In fact, our study extended to a human study that was recently investigated in a cell study by Kratochwill et al. [31] , showing an increased free radical production by mesothelial cells stimulated by PDE. We know from biochemistry that oxidation of the unique free SH in albumin sequence, i.e. Cys 34, produces two reversible intermediates, sulphenic (R-SOH) and sulphinic (R-SO 2 H) acid, while the end product is sulphonic acid (R-SO 3 H) that can be estimated by titration with specific C3NIASO3 fluorescence dye. The presence of this modification is associated with a decreased binding of the fluorescent dye and to a change in protein structure leading to proteosome degradation. We observed both changes in fluorescent dye binding indicating an amplified oxidation in our patient cohort and, in parallel, detected fragmentation products in PDE, but this aspect was not modified by Ico or by Glu. These results are still preliminary, and no definite conclusion can be drawn yet. However, it is noteworthy that albumin is the first antioxidant in PDE with a concentration higher than other classical antioxidants such as glutathione by a factor of 100 (0.8 vs. 0.006 mM). An improvement of antioxidant function in biological fluid such as in blood and in peritoneum is a potentially important aspect of individual defence since uraemia represents a predisposing conditions to oxidation per se. Moreover, glucose and other PD osmolytes could modify the albumin oxido-redox status, therefore reducing the physiological antioxidant potential. In this respect, the presence of intact albumin in PDE should represent a better host defence towards infectious stimuli than that of the oxidized form. A final point is whether these results could be extrapolated to adults. We have no answer for this point; even we argue about a potential benefit of removing oxidized albumin from plasma in adults.
In conclusion, we compared proteome profile of PDE obtained by using two PD solutions with different osmotic agents (glucose and icodextrin) in paediatric patients. PDE protein patterns were highly similar to plasma and urine proteome. The main difference between the two PD solutions was the capacity of icodextrin solution to remove a greater amount of proteins and, in particular, of oxidized proteins. These preliminary data could suggest some advantages in middle molecule and small protein removal by the use of icodextrin solution during chronic PD treatment, but the long-term clinical consequences of removing also potentially important molecules are to be defined. This capacity of icodextrin solution seems to be independent of the type of primary renal disease, residual renal function or dialysis duration. However, this issue needs to be addressed by extending the study longitudinally on a larger number of patients.
Our results extend the understanding of the mechanisms involved in protein transport through the PM. The role of proteins as first-line defence against ROS imbalance generated by chronic activation of macrophages during repetitive PD treatment should be further investigated.
